🇺🇸 FDA
Pipeline program

Allogeneic Cardiosphere-Derived Cells (CDCs)

CAP-1002 (DYNAMIC)

Phase 1 mab active

Quick answer

Allogeneic Cardiosphere-Derived Cells (CDCs) for Dilated Cardiomyopathy (DCM) is a Phase 1 program (mab) at CAPRICOR THERAPEUTICS, INC. with 1 ClinicalTrials.gov record(s).

Program details

Company
CAPRICOR THERAPEUTICS, INC.
Indication
Dilated Cardiomyopathy (DCM)
Phase
Phase 1
Modality
mab
Status
active

Clinical trials